Key result
Women undergoing bioresorbable vascular scaffold implantation had a primary composite event rate of 13.2% compared to 17.9% in men at two years.
Why the study?
Women and men with coronary artery disease differ in their risk profiles, prompting investigation into the impact of sex on two-year outcomes after BVS implantation in routine clinical practice.
Does female sex improve two-year clinical outcomes compared to male sex after Absorb bioresorbable vascular scaffold implantation for coronary artery disease?
Observational (n=1,032)
Yes
Does female sex improve two-year clinical outcomes compared to male sex after Absorb bioresorbable vascular scaffold implantation for coronary artery disease?
Answers are grounded in this paper and cite their sources.
In routine clinical practice, women undergoing BVS implantation tend to have numerically better outcomes than men, particularly regarding target lesion revascularization, potentially due to lower CAD complexity.
AIMS: Women and men suffering from coronary artery disease differ in their risk profiles. We sought to investigate the impact of sex on two-year outcomes after BVS implantation in routine clinical practice. METHODS AND RESULTS: Sex-based analysis of clinical outcomes was carried out by pooling the individual patient data of the ISAR-ABSORB and KUM-ABSORB registries performed in four high-volume tertiary centres in Munich. Of the total of 1,032 patients, 259 (25.1%) were women. The primary composite endpoint of death, target vessel myocardial infarction (TV-MI) and target lesion revascularisation (TLR) up to two years occurred in 13.2% of women and 17.9% of men (p=0.12). Compared to men, women experienced numerically lower rates of TLR and definite or probable BVS thrombosis - 7.5% vs 12.4% (p=0.051) and 1.2% and 2.7% (p=0.20), respectively. Independent predictors of increased risk for TLR were use of smaller size BVS (HR 1.28, 95% CI: 1.02-1.62), while being a woman was a protective factor (HR 0.59, 95% CI: 0.35-1.00). CONCLUSIONS: BVS used in a routine setting tend to perform better among women compared to men, which might be partially related to the lower complexity of their coronary artery disease.
No takes yet. Share an insight, caveat, or question.
Baquet et al. (2019) conducted an observational in coronary artery disease (n=1,032). Female sex vs. Male sex was evaluated on composite endpoint of death, target vessel myocardial infarction (TV-MI) and target lesion revascularisation (TLR) up to two years (p=0.12). Women undergoing bioresorbable vascular scaffold implantation had a primary composite event rate of 13.2% compared to 17.9% in men at two years.
Synapse has enriched 10 related papers. Consider them for comparative context: